Look for bargains in European stockmarkets
With the continent looking towards a robust recovery and markets at much lower valuations than the US, there are plenty of bargains to be found in European stocks.

The euro area is “nearing escape velocity”, says Christopher Graham of Standard Chartered. Economies have been gradually easing restrictions. France and Austria reopened restaurants last week, while Portugal and Italy are welcoming tourists from certain countries. The continent should enjoy a “robust recovery” now.
European vaccination rates picked up rapidly in April, says Ian Shepherdson of Pantheon Macroeconomics. More than half of the population should have had at least one jab by the end of June, only a month behind the US. Data from Israel suggests that “cases plummet… when vaccination rates exceed about 50%”.
Analysts turn positive
Germany’s Dax hit a new all-time high this week. Wall Street analysts are growing positive, says Sam Meredith for CNBC. Morgan Stanley thinks “Europe is well-placed to outperform all major regions this year for the first time in more than two decades”. With inflation anxiety affecting US markets, more US money managers are looking to the old continent.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The MSCI EMU index has outperformed the MSCI USA index since “vaccine Monday” on 9 November 2020 (the date when news of the Pfizer jab broke), says Franziska Palmas of Capital Economics. While Europe’s recovery will be weaker than America’s, its shares should keep outperforming.
US earnings forecasts are already very bullish, so a lot of good news is already priced in. In Europe a slower reopening has made analysts much more conservative, leaving room for positive surprises.
European markets are also far cheaper than their US counterparts. As of the start of this quarter the US market was trading on a cyclically adjusted price/earnings (Cape) ratio of 36.1. By contrast, Germany was on 19.9, France on 22.6 and Spain on just 14.7, according to Mebane Faber of Cambria Investment Management. That discount partly reflects compositional differences. The US has more fast-growing tech firms, while Europe has more value shares, such as banks and industrial firms.
Yet composition doesn’t explain the whole story. As Simon Edelsten notes in the Financial Times, even firms operating in similar industries are cheaper in Europe. Shares in German sportswear giant Adidas trade for “35 times this year’s earnings, but Nike in the US is on an eye-watering 42 times earnings”. The same is true of banks.
But “before dashing across the Channel like an excited shopper hunting for duty-free Gitanes and Château Plonque”, remember that cheap shares are sometimes cheap for a reason. Europe’s very best businesses – those that operate in sectors such as luxury goods and green energy – are rarely the cheapest. “Don’t be afraid to compromise on price in favour of prospects.”
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Inheritance tax reforms: government urged to rethink curbs on rural reliefs
MPs want the government to delay changes to inheritance rax reliefs for farmers
-
‘I’m among the thousands of millionaires leaving the UK – the new tax rules don’t make sense ’
MoneyWeek spoke to a serial entrepreneur who is leaving the UK following the abolition of the non-dom tax status
-
'Pension funds shouldn't be pushed into private equity sector'
Opinion The private-equity party is over, so don't push pension funds into the sector, says Merryn Somerset Webb.
-
Greg Abel: Warren Buffett’s heir takes the throne
Greg Abel is considered a safe pair of hands as he takes centre stage at Berkshire Hathaway. But he arrives after one of the hardest acts to follow in investment history, Warren Buffett. Can he thrive?
-
Who will be the next Warren Buffett?
Opinion There won’t be another Warren Buffett. Times have changed, and the opportunities are no longer there, says Matthew Lynn.
-
Will Comstock crash – or soar?
Opinion The upside for Comstock, a solar panel-recycling and biomass-refining group, dwarfs the downside, says Dominic Frisby.
-
'As AGMs go digital, firms must offer a new form of scrutiny for shareholders'
Opinion Technology has rendered big AGM meet-ups obsolete, but the board still needs to be held to account, says Matthew Lynn
-
Unilever braces for inflation amid tariff uncertainty – what does it mean for investors?
Consumer-goods giant Unilever has made steady progress simplifying its operations. Will tariffs now cause turbulence?
-
Two ways to tap into monopoly profits from airports
Most investors can’t get their hands on airports. Here are two ways you can
-
Fat profits: should you invest in weight-loss drugs?
The latest weight-loss treatments could transform public health and the world economy. Should you invest?